Zevra Therapeutics, Inc. Variable Lease, Payment
Zevra Therapeutics, Inc. (ZVRA) reported Variable Lease, Payment of $36.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:VariableLeasePayment · last filed 2026-03-09
- Zevra Therapeutics, Inc. variable lease, payment for the quarter ending 2025-12-31 was $0.00.
- Zevra Therapeutics, Inc. variable lease, payment for the quarter ending 2025-09-30 was $10.00K, a 61.54% decline year-over-year.
- Zevra Therapeutics, Inc. variable lease, payment for the quarter ending 2025-06-30 was $26.00K.
- Zevra Therapeutics, Inc. variable lease, payment for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Zevra Therapeutics, Inc. variable lease, payment for fiscal 2025 was $36.00K, a 7.69% decline from fiscal 2024.
- Zevra Therapeutics, Inc. variable lease, payment for fiscal 2024 was $39.00K, a 2.50% decline from fiscal 2023.
- Zevra Therapeutics, Inc. variable lease, payment for fiscal 2023 was $40.00K, a 2.56% increase from fiscal 2022.
- Zevra Therapeutics, Inc. variable lease, payment for fiscal 2022 was $39.00K, a 17.02% decline from fiscal 2021.
| Period end | Variable Lease, Payment 3 month | Variable Lease, Payment 6 month | Variable Lease, Payment 9 month | Variable Lease, Payment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $10.00K derived: sum of 2 quarters · filed 2026-03-09 | $36.00K derived: sum of 3 quarters · filed 2026-03-09 | $36.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $36.00K derived: sum of 2 quarters · filed 2025-11-05 | $36.00K 10-Q · filed 2025-11-05 | $36.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $26.00K 10-Q · filed 2025-08-12 | $26.00K derived: sum of 3 quarters · filed 2026-03-09 | $52.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $26.00K derived: sum of 3 quarters · filed 2026-03-09 | $26.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $26.00K derived: sum of 2 quarters · filed 2026-03-09 | $26.00K derived: sum of 3 quarters · filed 2026-03-09 | $39.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $26.00K derived: sum of 2 quarters · filed 2025-11-05 | $39.00K 10-Q · filed 2025-11-05 | $40.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $13.00K 10-Q · filed 2025-08-12 | $14.00K derived: sum of 3 quarters · filed 2025-08-12 | $27.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $13.00K 10-Q · filed 2025-05-13 | $14.00K derived: sum of 2 quarters · filed 2025-05-13 | $27.00K derived: sum of 3 quarters · filed 2025-05-13 | $40.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $14.00K derived: sum of 2 quarters · filed 2025-03-12 | $27.00K derived: sum of 3 quarters · filed 2025-03-12 | $40.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $26.00K derived: sum of 2 quarters · filed 2024-11-13 | $39.00K 10-Q · filed 2024-11-13 | $39.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $26.00K 10-Q · filed 2024-08-14 | $26.00K derived: sum of 3 quarters · filed 2024-08-14 | $39.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $13.00K 10-Q · filed 2024-05-09 | $13.00K derived: sum of 2 quarters · filed 2024-05-09 | $26.00K derived: sum of 3 quarters · filed 2024-05-09 | $39.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $13.00K derived: sum of 2 quarters · filed 2024-04-01 | $26.00K derived: sum of 3 quarters · filed 2024-04-01 | $39.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $26.00K derived: sum of 2 quarters · filed 2023-11-07 | $39.00K 10-Q · filed 2023-11-07 | $52.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $26.00K 10-Q · filed 2023-08-14 | $39.00K derived: sum of 3 quarters · filed 2023-08-14 | $52.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $13.00K 10-Q · filed 2023-05-15 | $26.00K derived: sum of 2 quarters · filed 2023-05-15 | $39.00K derived: sum of 3 quarters · filed 2023-05-15 | $47.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $26.00K derived: sum of 2 quarters · filed 2023-03-07 | $34.00K derived: sum of 3 quarters · filed 2023-03-07 | $47.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $21.00K derived: sum of 2 quarters · filed 2022-11-10 | $34.00K 10-Q · filed 2022-11-10 | $48.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $21.00K 10-Q · filed 2022-08-12 | $35.00K derived: sum of 3 quarters · filed 2022-08-12 | $49.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-12 | $27.00K derived: sum of 2 quarters · filed 2022-05-12 | $41.00K derived: sum of 3 quarters · filed 2022-05-12 | $54.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $28.00K derived: sum of 2 quarters · filed 2022-03-31 | $41.00K derived: sum of 3 quarters · filed 2022-03-31 | $55.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $27.00K derived: sum of 2 quarters · filed 2021-11-10 | $41.00K 10-Q · filed 2021-11-10 | $54.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $27.00K 10-Q · filed 2021-08-13 | $40.00K derived: sum of 3 quarters · filed 2021-08-13 | $54.00K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $14.00K 10-Q · filed 2021-05-14 | $27.00K derived: sum of 2 quarters · filed 2021-05-14 | $41.00K derived: sum of 3 quarters · filed 2021-05-14 | $47.00K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $27.00K derived: sum of 2 quarters · filed 2021-03-12 | $33.00K derived: sum of 3 quarters · filed 2021-03-12 | $48.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $20.00K derived: sum of 2 quarters · filed 2020-10-30 | $35.00K 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $21.00K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $15.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |